Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 25 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 8597946

    Enhanced dendritic cells for cancer immunotherapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  2. US 8580249

    Cell therapy for the treatment of lysosomal storage disorders

    Regents of the University of Minnesota · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  3. US 8557844

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  4. US 8551536

    Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  5. US 8546433

    Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer

    Rigel Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  6. US 8546371

    Nanoparticle formulated glycolipid antigens for immunotherapy

    The Board of Regents of the University of Texas System · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  7. US 8546091

    AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  8. US 8541185

    Method of predicting responsiveness to autologous adoptive cell transfer therapy

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  9. US 8536149

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  10. US 8529885

    AAV vectors for in vivo gene therapy of rheumatoid arthritis

    ACADEMISCH MEDISCH CENTRUM · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  11. US 8507437

    Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  12. US 8507551

    Antimicrobial therapy for bacterial infections

    The Regents of the University of California · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  13. US 8507445

    Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer

    The Board of Regents of the University of Texas System · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  14. US 8486370

    Heterocyclic ligands for integrin imaging and therapy

    The Regents of the University of California · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  15. US 8486385

    Methods for therapy of neurodegenerative disease of the brain

    The Regents of the University of California · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  16. US 8480995

    Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate

    UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  17. US 8481529

    Combination cancer chemotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  18. US 8475764

    Labelled adrenomedullin derivatives and their use for imaging and therapy

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  19. US 8476254

    Methods for treating psychosis associated with interferson-α therapy

    Corcept Therapeutics Incorporated · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  20. US 8470326

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  21. US 8470312

    Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

    ONCOLYTICS BIOTECH INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  22. US 8440168

    Image-guided therapy of myocardial disease: composition, manufacturing and applications

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted

  23. US 8435575

    Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

    Aphios Corporation · Granted May 7, 2013 · Expires May 2, 2033

    granted

  24. US 8414911

    Photochemical therapy to affect mechanical and/or chemical properties of body tissue

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.